Jazz Pharmaceuticals and JZP385 for ET

Staff from Jazz Pharmaceuticals give an update on the development of an investigational medicine for essential tremor, JZP385 in this video. Presenters are: Michelle Baladi, PhD, global development lead for JZP385, and Margaret Lee, PhD, early development lead for JZP385.

[@labmaier3426]

Thank you for doing such a great work!

[@Tremoring]

I don't qualify to volunteer, likely because there isn't one in my area. Would love to see the results of this. Such a frustrating thing to live with.

[@garydavis3032]

when will the Everst study result will be shared!🤔